|
Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search |
→ Previous article in this issue
→ Read the letter by Rasmussen et al
In reply: Rasmussen, Hansen and Nelson have missed the entire thrust of my article.1 When an individual calls a health professional for help, we can assume he or she agrees to standard treatment, but not to be placed into an experiment. Failure to inform patients that they are being placed into an experiment is a denial of basic human rights. I outlined a mechanism by which it would be possible to conduct an experiment such as RARE SALAMI that would comply with the appropriate guidelines and avoid denial of informed consent.
It is worth noting that failure to inform patients that they have been placed in a clinical experiment could also worsen our present medical indemnity crisis and lower the standing of medical research.
It has been shown how institutional ethics committees can be subjected to local pressures.2 As a result, it is possible some may adopt pseudolegalistic interpretations of accepted guidelines and approve studies that would be rejected elsewhere. This is another reason why informed consent is so important. Without it some studies simply can't be done.
Manly Non-Invasive Cardiac Laboratory, Manly, NSW.
Michael C Kennedy, MD, FRACP, Physician; and Research Associate, Department of Clinical Pharmacology, St Vincent's Hospital, Darlinghurst.Correspondence: Dr Michael C Kennedy, Manly Non-Invasive Cardiac Laboratory, Level 4, 22 Darley Road, Manly, NSW 2095. drmkennATozemail.com.au
|
Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search |
©The Medical Journal of Australia 2002 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377